LINKS
ABOUT

© 2019 by Qardian Labs.

GO FROM BIG DATA TO SMART DATA

HOW IT WORKS

Qardian builds on the latest developments in deep neural networks through our software product, HEARO:  Heart Evaluation for Algorithmic Risk-reduction and Optimization.

The algorithm works by using mathematical models to learn patterns in existing data, and then applying itself to predict outcomes for unfamiliar data.

CLINICAL WORKFLOW

To use the software, a doctor only needs to enter 11 metrics of patient information into our UI. Our software can be integrated with an EHR system, maximizing ease of use. With Qardian in an EHR, doctors will be able to view and analyze heart disease risk as part of a patient medical record.

PERFORMANCE EVALUATION

Both HEARO-11 and HEARO-14 achieve 99% accuracy on test data. HEARO-11 is evaluated with the University of California Irvine machine learning repository dataset. HEARO-14 is evaluated with UT student athlete data gathered by Head Team Physician Dr. Chris Klenck.

 

HEARO's extremely high accuracy is suggestive of its potential to provide doctors with a vital piece in the complex medical puzzle of heart disease diagnosis.

SUPERIOR ACCURACY

Our method outperforms previously published results, and can provide a significant improvement upon current heart disease risk assessment methods. 

 

HEARO benefits doctors by using deep learning to detect data relationships and output accurate results in under 5 minutes.

This research is described in further detail in the scientific paper, "On Deep Neural Networks for Detecting Heart Disease." Read more here.